首页> 外国专利> Purine derived compounds or pirrolopirimidina; and use to regulate, inhibit or modulate the activity of protein kinase in diseases such as cancer,Transplant rejection and autoimmune diseases.

Purine derived compounds or pirrolopirimidina; and use to regulate, inhibit or modulate the activity of protein kinase in diseases such as cancer,Transplant rejection and autoimmune diseases.

机译:嘌呤衍生的化合物或吡咯烷吡虫酰胺;并用于调节,抑制或调节癌症,移植排斥和自身免疫性疾病等疾病中蛋白激酶的活性。

摘要

The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases, particularly pyrrolopyrimidine compounds and derivatives are described which inhibit protein kinases. The organic compounds are useful in treating proliferative disease.
机译:本申请描述了可用于治疗,预防和/或改善疾病的有机化合物,特别是描述了抑制蛋白激酶的吡咯并嘧啶化合物和衍生物。有机化合物可用于治疗增生性疾病。

著录项

  • 公开/公告号CL2007001504A1

    专利类型

  • 公开/公告日2008-05-09

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号CL20070001504

  • 申请日2007-05-25

  • 分类号A61K31/519;A61K31/52;A61P35/00;A61P37/00;C07D473/26;C07D487/04;

  • 国家 CL

  • 入库时间 2022-08-21 20:08:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号